JP Morgan: Maintains "overweight" rating on MICROPORT (00853) and raises target price to HKD10.

J.P. Morgan released a research report stating that they maintain a "buy" rating for MICROPORT (00853), with a target price raised from HK$8 to HK$10. The firm reiterated its positive view on MICROPORT, describing the group as a diversified local leader in the Small and Medium-sized Medical Technology (SMID) sector, with strong innovative capabilities and overseas market expansion potential. They also expect the group to return to profitability by 2026 and continue to be their top choice in the SMID medical technology sector. J.P. Morgan also noted that the order trend for MEDBOT-B (02252), an important subsidiary of MICROPORT, is strong. They anticipate that due to the rapid expansion of installations by Siasun Robot & Automation in China and overseas, the former's contribution to the group's sales will increase from around 3% in 2024 to around 40% in 2033.